National Jewish Researchers Find Regular Use of Inhaled Beta-Agonist is

September 18, 1996

People who use beta-agonists on a regular schedule to control mild asthma symptoms receive no greater benefit than people who use beta-agonists only to control asthma symptoms as-needed, according to an article published today in the New England Journal of Medicine.

"Fixed-schedule use of the beta-agonist was no better than if the patient used it when they needed it," explains Richard Martin, M.D., a physician at National Jewish Center for Immunology and Respiratory Medicine and principal investigator of the NIH Asthma Clinical Research Network (ACRN) in Denver. In addition, patients who use a beta-agonist only as-needed realize some cost savings.

Researchers participating in this multi-center National Institutes of Health study also found that using beta-agonists regularly causes no adverse health effects, as had been thought.

"This study shows that if a patient with mild asthma needs to use their inhaler more frequently, the inhaler is not making the disease worse," Dr. Martin says. "Patients who use beta-agonists on a fixed schedule have a good response even after using the medication for several months."

The ACRN study followed 255 patients with mild asthma, ages 12 to 55, for 6 months. After a 6-week evaluation period, patients received the inhaled beta-agonist, albuterol, 2 puffs 4 times a day, or an identical-appearing placebo inhaler for 16 weeks. Patients in both groups were permitted to take additional albuterol, when needed for relief of asthma symptoms. During a final 4-week withdrawal period, all patients received only as-needed albuterol.

The study showed that even though the average use of albuterol was 5 times higher in the regular-use group than in the as-needed group, there were no significant differences between the two groups in measures of lung function, asthma symptoms, or quality of life that could be attributed to the treatment. But people with mild asthma who continue to expand their use of a beta-agonist may have some cause for concern. "Increased inhaler use likely is a sign of worsening asthma and signals the need for a patient to contact their physician," Dr. Martin says.

Beta-agonists provide relief of asthma symptoms by relaxing airway smooth muscle, but do not treat the underlying inflammation that produces the symptoms.

Asthma is a chronic lung disease that affects more than 13 million Americans. The frequency, severity of illness, and death rate from the disease all have been increasing steadily for more than a decade. Asthma also is a major cause of lost wages and school absenteeism, resulting in estimated annual health care costs of more than $4.6 billion. The National Heart, Lung, and Blood Institute's Communications Office contributed to this release.
Internet site: http://www.njc.org/pa

National Jewish Health

Related Asthma Articles from Brightsurf:

Breastfeeding and risks of allergies and asthma
In an Acta Paediatrica study, exclusive breastfeeding for the first 3 months was linked with a lower risk of respiratory allergies and asthma when children reached 6 years of age.

Researchers make asthma breakthrough
Researchers from Trinity College Dublin have made a breakthrough that may eventually lead to improved therapeutic options for people living with asthma.

Physics vs. asthma
A research team from the MIPT Center for Molecular Mechanisms of Aging and Age-Related Diseases has collaborated with colleagues from the U.S., Canada, France, and Germany to determine the spatial structure of the CysLT1 receptor.

New knowledge on the development of asthma
Researchers at Karolinska Institutet in Sweden have studied which genes are expressed in overactive immune cells in mice with asthma-like inflammation of the airways.

Eating fish may help prevent asthma
A scientist from James Cook University in Australia says an innovative study has revealed new evidence that eating fish can help prevent asthma.

Academic performance of urban children with asthma worse than peers without asthma
A new study published in Annals of Allergy, Asthma and Immunology shows urban children with poorly controlled asthma, particularly those who are ethnic minorities, also suffer academically.

Asthma Controller Step Down Yardstick -- treatment guidance for when asthma improves
The focus for asthma treatment is often stepping up treatment, but clinicians need to know how to step down therapy when symptoms improve.

Asthma management tools improve asthma control and reduce hospital visits
A set of comprehensive asthma management tools helps decrease asthma-related visits to the emergency department, urgent care or hospital and improves patients' asthma control.

Asthma linked to infertility but not among women taking regular asthma preventers
Women with asthma who only use short-acting asthma relievers take longer to become pregnant than other women, according to research published in the European Respiratory Journal.

What are the best ways to diagnose and manage asthma?
A team of experts from The University of Texas Medical Branch at Galveston examined the current information available from many different sources on diagnosing and managing mild to moderate asthma in adults and summarized them.

Read More: Asthma News and Asthma Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.